Life-threatening superbug spreads globally in cystic fibrosis patients A multidrug-resistant superbug infection that can cause life-threatening illness in people with cystic fibrosis (CF) has spread globally and is becoming increasingly virulent, British researchers said on Thursday.
Breast cancer: The first sign isn't always a lump Around 1 in 6 women eventually diagnosed with breast cancer initially go to their doctors with a symptom other than a lump, according to a new study conducted in England
Italian oncologist seen as father of cancer research dies Umberto Veronesi, an Italian oncologist, former health minister and senator widely respected for his work on preventing and treating breast cancer, has died, his foundation said.
Age may not affect breast reconstruction complications Despite concerns, older women don't have more complications with breast reconstruction procedures than younger women, a new U.S. study suggests.
8-year-old to walk in fashion show after cancer battle An 8-year-old recently declared cancer-free will walk in an upcoming fashion show on Saturday to benefit the National Pediatric Cancer Foundation.
Second opinions not likely to change prostate cancer treatment Though many men diagnosed with prostate cancer seek a second opinion before beginning treatment, second opinions are unlikely to change their treatment decisions, according to a U.S. study.
Childhood cancer survivors have lasting health problems even with newer treatments Despite advances that have made treatments safer and more effective, childhood cancer survivors don't appear to have experienced gains in long-term health outcomes, a new study suggests.
Adding music to pain meds may reduce pain As a complement to traditional pain relief tools like medication, listening to music may lessen acute or chronic pain related to cancer and other conditions, according to a new review.
Roche advances skin cancer trials as part of combination therapy strategy Roche is pressing ahead with two skin cancer trials that combine its immunotherapy Tecentriq with other drugs after early data showed the treatments were well-tolerated and effective in a small number of patients, the company said Monday.
Roche says flexible pricing ready for cancer, not MS drugs The spotlight on finding a cancer cure has spurred improvements in systems to collect and analyze oncology data, but efforts to track patients with other diseases lag behind, Roche pricing head Jens Grueger said.
